Gurbakhash Kaur, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in stem cell transplantation, immunotherapy, CAR T-cell therapy, and treating patients with multiple myeloma and other plasma cell disorders, including amyloidosis and Waldenström macroglobulinemia. She is also involved in clinical trials to develop novel therapeutics for multiple myeloma.

Dr. Kaur earned her medical degree at Drexel University College of Medicine. She completed a residency in internal medicine at Tufts Medical Center and received advanced training in hematology and oncology through a fellowship at Montefiore Medical Center.

Certified by the American Board of Internal Medicine in medical oncology and in hematology, she joined the UT Southwestern faculty in 2020.

Dr. Kaur’s clinical and research interests include improving outcomes for patients with hematologic malignancies, particularly multiple myeloma, by developing newer cellular and immunotherapy therapies, and she publishes and delivers presentations on her work regularly.

She is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the International Myeloma Society, among other professional organizations.

Education & Training
  • Medical School - Drexel University College of Medicine (2009-2013)
  • Residency - Tufts Medical Center (2013-2016), Internal Medicine
  • Fellowship - Montefiore Medical Center (2016-2019), Hematology Oncology
  • Graduate School - Boston University School of Medicine (2007-2009)
Professional Associations & Affiliations
  • American Society of Hematology
  • American Society of Clinical Oncology
  • International Myeloma Society
  • American Society for Transplantation and Cellular Therapy
  • European Hematology Association
Honors & Awards
  • Master’s Thesis with Honors 2009, Boston University School of Medicine
  • Techno-Genesis Summer Scholar 2005-2006, Stevens Institute of Technology
Books & Publications
  • Hematologic Malignancies
  • Immunotherapy
  • Health Care Disparities

Clinical Focus

  • Multiple Myeloma
  • Cellular therapy (CAR T-cell)
  • Bone Marrow Transplant
  • Amyloidosis
  • Monoclonal Gammopathies of Unknown Significance (MGUS)
  • Smoldering Myeloma
  • Waldenström Macroglobulinemia

See More

Gurbakhash Kaur, M.D.

Dr. Kaur talks about her approach to patient care.